Aadi Bioscience Stock Beta
| AADI Stock | USD 1.84 0.06 3.16% |
Aadi Bioscience fundamentals help investors to digest information that contributes to Aadi Bioscience's financial success or failures. It also enables traders to predict the movement of Aadi Stock. The fundamental analysis module provides a way to measure Aadi Bioscience's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Aadi Bioscience stock.
Aadi | Beta |
Aadi Bioscience Company Beta Analysis
Aadi Bioscience's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current Aadi Bioscience Beta | 0.3 |
Most of Aadi Bioscience's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Aadi Bioscience is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Aadi Beta Driver Correlations
Understanding the fundamental principles of building solid financial models for Aadi Bioscience is extremely important. It helps to project a fair market value of Aadi Stock properly, considering its historical fundamentals such as Beta. Since Aadi Bioscience's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Aadi Bioscience's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Aadi Bioscience's interrelated accounts and indicators.
Click cells to compare fundamentals
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, Aadi Bioscience has a Beta of 0.298. This is 65.35% lower than that of the Biotechnology sector and 78.56% lower than that of the Health Care industry. The beta for all United States stocks is notably lower than that of the firm.
Aadi Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Aadi Bioscience's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Aadi Bioscience could also be used in its relative valuation, which is a method of valuing Aadi Bioscience by comparing valuation metrics of similar companies.Aadi Bioscience is currently under evaluation in beta category among related companies.
Aadi Bioscience Institutional Holders
Institutional Holdings refers to the ownership stake in Aadi Bioscience that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Aadi Bioscience's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Aadi Bioscience's value.| Shares | Baker Bros Advisors Lp | 2023-12-31 | 251.7 K | Citadel Advisors Llc | 2023-09-30 | 236.3 K | 683 Capital Management Llc | 2023-12-31 | 200 K | Northern Trust Corp | 2023-12-31 | 162.4 K | Ameriprise Financial Inc | 2023-12-31 | 103.5 K | Lion Point Capital, Lp | 2023-12-31 | 82.4 K | Bank Of New York Mellon Corp | 2023-12-31 | 50 K | Squarepoint Ops Llc | 2023-12-31 | 46.2 K | Charles Schwab Investment Management Inc | 2023-12-31 | 45.4 K | Venbio Select Advisor Llc | 2023-12-31 | 2.8 M | Longwood Capital Partners Llc | 2023-12-31 | 1.8 M |
As returns on the market increase, Aadi Bioscience's returns are expected to increase less than the market. However, during the bear market, the loss of holding Aadi Bioscience is expected to be smaller as well.
Aadi Fundamentals
| Return On Equity | -0.5 | ||||
| Return On Asset | -0.28 | ||||
| Profit Margin | (2.70) % | ||||
| Operating Margin | (2.80) % | ||||
| Current Valuation | (60.93 M) | ||||
| Shares Outstanding | 24.55 M | ||||
| Shares Owned By Insiders | 12.40 % | ||||
| Shares Owned By Institutions | 52.84 % | ||||
| Number Of Shares Shorted | 943.07 K | ||||
| Price To Book | 0.46 X | ||||
| Price To Sales | 1.98 X | ||||
| Revenue | 24.35 M | ||||
| Gross Profit | (18.78 M) | ||||
| EBITDA | (71.76 M) | ||||
| Net Income | (65.77 M) | ||||
| Cash And Equivalents | 118.74 M | ||||
| Cash Per Share | 5.65 X | ||||
| Total Debt | 7.02 M | ||||
| Debt To Equity | 0.02 % | ||||
| Current Ratio | 9.87 X | ||||
| Book Value Per Share | 4.28 X | ||||
| Cash Flow From Operations | (59.66 M) | ||||
| Short Ratio | 1.53 X | ||||
| Earnings Per Share | (2.44) X | ||||
| Target Price | 11.67 | ||||
| Number Of Employees | 89 | ||||
| Beta | 0.3 | ||||
| Market Capitalization | 46.65 M | ||||
| Total Asset | 132.42 M | ||||
| Retained Earnings | (268.96 M) | ||||
| Working Capital | 98.19 M | ||||
| Net Asset | 132.42 M |
About Aadi Bioscience Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Aadi Bioscience's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aadi Bioscience using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aadi Bioscience based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Aadi Bioscience
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aadi Bioscience position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aadi Bioscience will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Aadi Bioscience could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aadi Bioscience when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aadi Bioscience - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aadi Bioscience to buy it.
The correlation of Aadi Bioscience is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aadi Bioscience moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aadi Bioscience moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aadi Bioscience can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Aadi Bioscience Piotroski F Score and Aadi Bioscience Altman Z Score analysis. For more detail on how to invest in Aadi Stock please use our How to Invest in Aadi Bioscience guide.Note that the Aadi Bioscience information on this page should be used as a complementary analysis to other Aadi Bioscience's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Complementary Tools for Aadi Stock analysis
When running Aadi Bioscience's price analysis, check to measure Aadi Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aadi Bioscience is operating at the current time. Most of Aadi Bioscience's value examination focuses on studying past and present price action to predict the probability of Aadi Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aadi Bioscience's price. Additionally, you may evaluate how the addition of Aadi Bioscience to your portfolios can decrease your overall portfolio volatility.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |
Is Aadi Bioscience's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aadi Bioscience. If investors know Aadi will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aadi Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.44) | Revenue Per Share 0.905 | Quarterly Revenue Growth 0.21 | Return On Assets (0.28) | Return On Equity (0.50) |
The market value of Aadi Bioscience is measured differently than its book value, which is the value of Aadi that is recorded on the company's balance sheet. Investors also form their own opinion of Aadi Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Aadi Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aadi Bioscience's market value can be influenced by many factors that don't directly affect Aadi Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aadi Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aadi Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aadi Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.